Clinical Trial Update: To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol [Phase 4]

View source ↗

Summary

This Phase 4 trial update investigates whether baseline reversibility predicts the efficacy of indacaterol in chronic obstructive pulmonary disease. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED